Overview Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults Status: Completed Trial end date: 2008-02-01 Target enrollment: Participant gender: Summary The study will evaluate the safety and pharmacokinetics of single doses of VBY-376 in healthy subjects. Phase: Phase 1 Details Lead Sponsor: Virobay Inc.